<?xml version="1.0" encoding="UTF-8"?>
<p id="P26">Foscarnet is approved for the treatment of CMV retinitis in patients with AIDS.
 <sup>
  <xref ref-type="bibr" rid="R58">58</xref>
 </sup> It has been used to treat other CMV diseases in immunocompromised patients, especially those unable to tolerate ganciclovir and those infected with ganciclovir-resistant virus.
 <sup>
  <xref ref-type="bibr" rid="R60">60</xref>,
  <xref ref-type="bibr" rid="R61">61</xref>
 </sup> Foscarnet is also used for treating acyclovir-resistant mucocutaneous HSV and VZV in immunocompromised patients.
 <sup>
  <xref ref-type="bibr" rid="R58">58</xref>
 </sup> On rare occasion, it has been used for prevention of CMV in transplant recipients; however, its toxicity limits this clinical indication.
 <sup>
  <xref ref-type="bibr" rid="R60">60</xref>,
  <xref ref-type="bibr" rid="R61">61</xref>
 </sup>
</p>
